Navigation Links
DrugRisk Adds Latest Court Information For Januvia Lawsuits
Date:11/12/2013

New York, NY (PRWEB) November 12, 2013

The diabetes drug safety center at DrugRisk.com is alerting patients taking the medications Januvia or Janumet of new information on the site. A federal court overseeing a growing number of lawsuits alleging drugs like these caused pancreatic cancer has set the next hearing for next week. The formal case is known as In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452 (Southern District of California).

The DrugRisk Center was created to give those taking popular prescription drugs the latest product recalls, safety alerts, research and litigation news. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Januvia and Janumet are popular oral diabetes medications prescribed to those with type-2 diabetes, taken twice a day to lower blood sugar levels. In recent years, they have been the best-selling drugs for pharmaceutical company Merck*.

However, DrugRisk has added studies warning of a risk of Januvia cancer. In 2011, researchers from UCLA discovered subjects given Januvia had increased rates of pancreatic cancer and thyroid cancer**. The American Medical Association recently advised diabetes drugs like these can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).

DrugRisk has added the latest court records showing 150 cases have already been filed alleging cancer from the drug class including Januvia, Byetta, Janumet or Victoza****. Judge Anthony Battaglia, who is overseeing the litigation, has scheduled the next Status Conference for November 21, 2013.

Anyone affected by cancer after taking Januvia or Janumet is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****Judicial Panel on Multidistrict Litigation, 10/17/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf

Read the full story at http://www.prweb.com/releases/januvia-warnings-2013/side-effects-lawsuit/prweb11327985.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2019)... ... December 06, 2019 , ... ... and manufacturing implantable medical devices, which is a new and rapidly growing segment ... implantable medical devices are surgically inserted into various parts of the human body. ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... the preferred HIPAA compliance solution for the Wyoming Medical Society. Compliancy Group is ... , Healthcare entities have an obligation to adhere to the standards set forth ...
(Date:12/5/2019)... SAN MATEO, Calif. (PRWEB) , ... December 05, 2019 , ... ... alike fall asleep over 25 million times this year using Bible-based bedtime stories. Listeners ... with refreshed minds. , According to the Center for Disease Control, one third of ...
(Date:12/4/2019)... ... 04, 2019 , ... A November 12 article on NBC Connecticut ... transit options. The article highlighted the life-changing or life-ending consequences of some E-scooter accidents, ... a rider fatality after an incident with a vehicle. Los Angeles-based personal injury law ...
(Date:12/4/2019)... ... 2019 , ... UNC Health Care has introduced a new mobile app that ... UNC Medical Center in Chapel Hill and UNC REX Healthcare in Raleigh. The Smartphone ... The free interactive app, developed by Gozio Health, also gives patients access to physician ...
Breaking Medicine News(10 mins):
(Date:12/9/2019)... , ... December 09, 2019 , ... ... most people contend with are not ‘sebaceous,’” notes Dr. Robert Levine, a dual-board-certified ... epidermoid – also called ‘epidermal’ – cysts, which have their own distinct structure.” ...
(Date:12/8/2019)... ... December 07, 2019 , ... The 12-Step ... weekly ongoing face-to-face mutual support groups in 32 countries. At meetings members share ... members also provide several daily phone and internet meetings. This expands the means ...
(Date:12/6/2019)... (PRWEB) , ... December 06, 2019 , ... ... 800, targeted for implementation this month, Kenall is introducing the CSEDOIC luminaire series. ... controlled. USP 800 now requires the unpacking of hazardous drugs (HDs) and HD-active ...
Breaking Medicine Technology: